Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Skin health and diseases are closely linked to metabolic processes.

Women are more likely to have long-term post-COVID symptoms than men.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Many people in Majmaah city, Saudi Arabia, don't know much about vitamin D deficiency and don't practice good vitamin D habits, with few linking it to hair loss.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.